U.S. markets close in 3 hours 20 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.39+0.52 (+10.68%)
As of 12:38PM EDT. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
0
0
Operating Expense
11,819
7,154
8,015
11,231
10,544
Operating Income
-11,819
-7,154
-8,015
-11,231
-10,544
Net Non Operating Interest Income Expense
15.476
28.798
15.213
6.519
-801.721
Other Income Expense
-
-
433.392
-1,005
597.615
Pretax Income
-11,804
-7,126
-7,566
-12,230
-10,749
Net Income Common Stockholders
-11,804
-7,126
-7,566
-12,230
-10,749
Average Dilution Earnings
-
-
0
-
-
Diluted NI Available to Com Stockholders
-11,804
-7,126
-7,566
-12,230
-10,749
Basic EPS
-
0
0
0
-0.0012
Diluted EPS
-
0
0
0
-0.0012
Basic Average Shares
-
22,296
16,602
14,898
9,338
Diluted Average Shares
-
22,296
16,602
14,951
9,338
Total Operating Income as Reported
-11,819
-7,154
-8,015
-11,231
-10,544
Total Expenses
11,819
7,154
8,015
11,231
10,544
Net Income from Continuing & Discontinued Operation
-11,804
-7,126
-7,566
-12,230
-10,749
Normalized Income
-11,804
-7,126
-7,999
-11,224
-11,346
Interest Income
18.39
28.798
15.213
-
-
Net Interest Income
15.476
28.798
15.213
6.519
-801.721
EBIT
-11,830
-7,154
-8,015
-11,231
-10,544
EBITDA
-11,830
-
-
-
-
Net Income from Continuing Operation Net Minority Interest
-11,804
-7,126
-7,566
-12,230
-10,749
Total Unusual Items Excluding Goodwill
-
-
433.392
-1,005
597.615
Total Unusual Items
-
-
433.392
-1,005
597.615
Normalized EBITDA
-11,830
-7,154
-8,448
-10,225
-11,142
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0